Description
COMPOSITION: Each tablet contains Sofosbuvir 400 mg + Daclatasvir 60 mg
INDICATION: SOFOKAST PLUS is a fixed dose combination of hepatitis c virus nucleotide analog NSSB polymerase inhibitor and NSSA inhibitor indicated for the treatment of:
- Adult patients with genotype 1, 2, 3 or 4 chronic HcV inf9ction without cirrhosis or with c0mpensated cirrhosis pax of c0mbination antiviral treatment regimen.
PACKING: 28 Tablets / Bottle